☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Precision BioSciences
Precision BioSciences’ Partner TG Therapeutics Receives the US FDA’s IND Clearance to Advance Azer-Cel for Multiple Sclerosis
August 9, 2024
Precision Signs Multiple Agreements with Novartis to Develop an In Vivo Gene Editing Therapies for Sickle Cell Disease and Beta Th...
June 22, 2022
Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value
February 11, 2021
PharmaShots Weekly Snapshot (Nov 23 - 27, 2020)
November 27, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
